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Based on similarities between capsid structure, genome organization, 
and replication strategy, rotaviruses have been classified a separate 
genus (Rotavirus) within the Reoviridae family. Differences in the 
antigenic properties, gene sequences and the genome pattern serve as the 
basis for further classification within the genus; serogroups (groups), 
subgroups, serotypes and genotypes, and electropherotypes are 
distinguished. The inner shell protein, VP6, is the group and subgroup-
specific antigen. There are at least seven groups (designated A to G), 
three of which (group A, B, and C) cause disease in humans. Within 
group A rotaviruses, four subgroups (sg) are distinguished (sgI, sgII, 
sgI+II, and sg nonI-nonII). Serotype and genotype specificities are 
carried by the two outer capsid antigens, VP7 and VP4. The VP7 antigen 
determines the G (Glycoprotein) serotypes/genotypes and the VP4 
antigen determines the P (Protease sensitive) serotypes/genotypes. The 
use of the terms serotype and genotype depends on whether antigen 
based detection methods (MAb-ELISA, cross-neutralization assay) or 
nucleic acid based detection methods (nucleotide sequencing, RT-PCR, 
oligonucleotide probe hybridization) are utilized. At present, 15 G types 
and 27 P types are known; of these, 11 G types and 12 P types have been 
detected in humans. Both surface antigens elicit neutralizing antibodies. 
This perception led to the introduction of a dual nomenclature for group 
A rotavirus strains (similarly to that of utilized for influenza A viruses), 
where the P type specificity is followed by G type specificity (e.g., 
P[9],G3). Rotaviruses can be classified into two major genome patterns 
(also called as RNA profile, electropherotype, or E-type), which are 
designated as ‘long’ and ‘short’ profile based on differences in the 
relative migration pattern of genome segments 10 and 11 in 
polyacrylamide gels. However, a large extent of pattern variability has 
been found within the two major electropherotypes. 
 
Human rotaviruses were first described in 1973. Since then, partly due to 
the wide availability of rapid diagnostic tests, it has been found that 
these pathogens, especially group A rotaviruses, are the major cause of 
childhood gastroenteritis cases. An estimated 130-140 million episodes 
and 400-500 thousand fatal cases occur each year worldwide, most cases 
occur in children younger than 5 years. Although the mortality has been 
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estimated to continuously decrease by the 1990s, rotaviruses are still 
responsible for one-fourth of childhood diarrhea-associated deaths. 
Rotavirus infections can be efficiently treated with oral or intravenous 
electrolyte and fluid supplementation. However, due to the regional 
inequalities in medical care and to economic and societal burden, the 
WHO gave priority to vaccine development in the fight against rotavirus 
disease. One of the leading vaccine development strategies which was 
developed in the 1980s is based on two basic observations: (i) the 
majority of animal strains are naturally attenuated for humans, and (ii) 
serotype-specific immunity is important to prevent subsequent episodes. 
Multivalent animal-human reassortant vaccines have been developed, 
which include a mixture of human VP7, and, occasionally of VP4 type 
specificities (G1 to G4, and P[8]). A common feature of these vaccines 
is that each individual vaccine strain carries 10 gene segments from the 
animal parental strain (simian or bovine) and a single gene segment 
(encoding the VP7 and/or the VP4) is of human origin. The rhesus 
rotavirus based quadrivalent vaccine (rhesus-human reassortant 
tetravalent vaccine, RRV-TV) with the trademark name, RotaShieldTM, 
was introduced in the United States during the Autumn of 1998, but in 
nine months of routine use it was withdrawn from the market due to the 
recognition of its possible association with intussusception. Currently, a 
bovine-based pentavalent reassortant vaccine (RotaTeqTM, Merck) and a 
monovalent vaccine that includes an attenuated human strain 
(RotaRixTM, GlaxoSmithKline Biologicals) await licensure in many 
countries including those in the European Union.  
 
Since the mid 1990s, in association with the possible implementation of 
national vaccination programs against rotaviruses, numerous countries 
have initiated surveys to estimate the rotavirus related disease burden 
and have started national rotavirus strain surveillance programs. In 
association with the vaccination strategies, the surveillance is focussing 
on determination of the sero- and genotypes of outer capsid antigens, 
VP7 and VP4. With the exception of a single paper, no serotyping 
studies were published in Hungary, resulting in significant gaps in our 
knowledge about the antigenic and genetic features of locally circulating 
human rotaviruses. The general need to gain more comprehensive and 
detailed data about the epidemiologic features of rotavirus infections and 






Our aims were to: 
- assess the relative importance of rotavirus infections in children 
admitted to hospital with gastroenteritis of infectious origin; 
- screen a large number of rotavirus positive stool samples by using 
MAb-ELISA and PAGE; 
- set up RT-PCR genotyping assay needed in the epidemiological 
surveys; 
- determine the geographic and temporal variations in the 
distribution of VP7 serotypes; 
- determine the diversity and genetic variability of the minor outer 
capsid antigen, VP4; 
- explore the most common and less frequent allele combinations 
and thus identify reassortant strains by using a combination of 
typing methods (i.e., RNA pattern analysis, subgrouping, sero- and 
genotyping); 
- reveal the possible phylogenetic relationships between human and 
animal rotaviruses; 
- adapt and grow rare human strains in cell culture; 
- design and utilize molecular reagents to the surveillance; 
- provide information for health care policy makers about the 
epidemiological findings that would give supporting information 
when decisions are made about the possible introduction of  a 
rotavirus vaccine in Hungary. 
 
Materials and methods 
 
Stool specimens: Rotavirus positive stool samples were collected from 
children admitted to hospitals with diarrhea from two geographical 
regions (Baranya County and Budapest) between 1992 and 2003. The 
laboratory diagnosis was performed in the Regional Laboratory of 
Virology (ANTSZ, Baranya County Institute of State Public Health 
Service, Pécs) and in the Laboratory for Diagnostic Virology (“St 





Detection of rotaviruses: Routine diagnostic procedures were carried out 
using a commercial latex-agglutination test (Rotalex, Orion Diagnostica) 
and an immunochromatographic test (Rota Uni-Strip, Coris BioConcept) 
according to the manufacturer’s instruction or a home-made enzyme-
linked immunosorbent-assay (ELISA). In part with the aim to confirm 
antigen detection results, we investigated the genome pattern analysis by 
polyacrylamide gel electrophoresis (PAGE). Lastly, we attempted to 
adapt a few rare strains to cell culture.  
 
Molecular epidemiological investigations: PAGE was used to detect 
mixed infections and differences among individual strains, and to follow 
changes in the geographical and temporal distribution of 
epidemiologically major and minor strains. Subgroup determination was 
performed with monoclonal antibody based ELISA (MAb-ELISA). The 
serotype and genotype of the surface antigens were determined by 
serotype-specific MAb-ELISA and multiplex reverse transcription-
polymerase chain reaction (RT-PCR), respectively. In certain cases, 
nucleotide sequencing and phylogenetic analysis was also done. 
 
Computer analysis: Raw sequence data were edited using the GeneDoc 
software. Edited sequences and reference sequences downloaded from 
DNA data bases (GenBank/EMBL/DDJB) were aligned with ClustalX 
or DAMBE. Phylogenetic inference was performed with the neighbor-
joining algorithm and bootstrapping for the statistical analysis using the 
software MEGA2 and with the maximum-likelihood using the software 




Identification of human rotaviruses in gastroenteritis cases. In general, 
we had only approximate data on the proportion of rotavirus positive 
cases. For example, at the St. László Hospital rotavirus was detected in 
20-40% in stool samples of children hospitalized with gastroenteritis. 
[Mihály I., personal communication]. There was somewhat more reliable 
data available from our diagnostic practice in Baranya County, partly in 
association with the extensive co-operative relationship with the 
Infectious Ward of Baranya County Children’s Hospital. Between 1996 
and 2000, the proportion of rotavirus positive cases was 21% (annual 
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range: 15-29%) in Baranya County. By the numerical comparison of 
annual cases we realized that the proportion of infants and young 
children admitted to hospital with rotavirus infection is higher than the 
proportion of children admitted with infections due to enteric bacteria, 
and the cumulative risk for hospitalization of children by the age of 5 
years is twice, thrice, and forty times higher for rotavirus than the 
corresponding risk associated with infections due to Salmonella, 
Campylobacter and Shigella. These data demonstrate the leading 
etiology of rotaviruses in childhood enteric infections.  
 
Identification of human rotaviruses by genome pattern analysis. The 
electrophoretic analysis of the 11 genomic segments of rotaviruses was 
done to supplement antigen based diagnostic results and to perform 
prospective molecular epidemiological investigation. Altogether 6936 
samples were analyzed between 1992 and 2003; the proportion of 
electropherotypeable strains was ~80%. The remaining samples were 
negative by this method or were not electropherotypeable due to the lack 
of certain genome segments. The relative proportions of the two major 
electropherotypes, ‘long’ (L) and ‘short’ (S), were 94% and 6%, 
respectively. Within both major RNA profiles we identified at least 7-10 
different major patterns and an additional 7-10 minor electropherotype 
variants. During the 13-year study, the predominant electropherotypes 
were different each year in both areas (Budapest and Baranya County) 
and with the exception of the 1996-1997 Budapest season, the ‘long’ E-
type strains predominated each season. 
 
Occurrence of human rotavirus G types in Hungary. A total of 3537 
samples were G typed between 1992 and 2003 by MAb-ELISA and RT-
PCR. Depending on the amount of original stool samples, 15% to 82% 
of specimens (mean, ~51%) were subjected to G typing. Altogether, 
2563 strains were examined with serotyping ELISA, of which 1971 
(77%) were successfully G typed, and 1604 strains were examined with 
genotyping RT-PCR (including 530 samples that were not serotypeable 
with MAb-ELISA), of which 1556 (97%) were genotypeable. Compiling 
the G typing results from the ELISA and RT-PCR, we could determine 
the G type for 3270 strains (93%). 
Among these strains, six G types (G1, G2, G3, G4, G6, and G9) 
were identified. When examining the relative importance of these six G 
types, we found that G1 strains are the most prevalent (58%). Serotype 
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G9 strains were found to be the second most frequent rotaviruses (16%) 
although their circulation in Hungary was only shown as late as 1998 
and spread to a wider region only in 2000. The globally common G 
types, G2 (8%), G3 (1,5%), and G4 (6%) together, demonstrated a 
comparable frequency with the G9 strains (15.5% vs. 16%). The least 
frequent strains were of serotype G6 (~1%). 
Remarkable seasonal and geographical variations have been seen 
in the strain prevalence. Among the six identified G types, G1 strains 
predominated in seven of eight seasons in Baranya County, and nine of 
11 seasons in Budapest and the metropolitan area. The relative 
frequency of G1 strains varied year-by-year (range, 23% to 100%). 
Consistent with this finding we recognized shifts in serotype prevalence 
in certain seasons: in those particular seasons, serotype G2 (42%; 
Budapest, 1996-1997), G4 (43%; Baranya County, 1999-2000), and G9 
(51%; Budapest, 2002-2003) rotaviruses emerged to become the 
predominant strains. An intriguing observation was that during the 
serotype shift in 1999-2000 in Baranya County, the number of rotavirus-
associated hospitalizations has significantly increased.  
 
Occurrence of human rotavirus P types in Hungary. The P type of 
circulating rotaviruses was determined with multiplex RT-PCR 
genotyping. A total of 1457 strains were subjected to P typing and 1413 
(97%) of those strains were successfully P typed. 
Although the total number of strains included in P typing was 
relatively high, we could not provide true prevalence data because of 
sampling bias in the early study period. While only 284 strains were P 
typed between 1992 and 2000, the total number of P typed strains in the 
2000-2003 period was as high as 1173. In spite of this bias in sample 
selection five different, including two rare P types were identified. 
These P types were P[4], P[6], P[8], P[9], and P[14], of which, 
with the exception of a single identified P[14] strain, all P types 
circulated in both regions, in each season.  
Comprehensive data on the relative frequency of P types were 
available only for the 2000-2003 study period. In this short period we 
observed the dominating prevalence of genotype P[8] strains (89%); 
genotype P[4] (3%), P[6] (~1%), and P[9] (~2%) strains circulated at 




Common and rare genome patterns and antigen combinations. To 
explore the genetic heterogeneity of concurrently circulating strains and 
to understand the importance of reassortment we compiled the data from 
E-, G- and P typing and subgrouping, although due to the low quantity 
of subgroup-specific monoclonal antibodies this complete picture could 
be drawn only for two-hundred samples or so. The analysis of the 
constellation of genome pattern and different antigen specificities (VP6, 
VP7, and VP4) demonstrated the occurrence of the globally spread gene 
combinations (P[8],G1 sgII L; P[4],G2 sgI S; P[8],G3 sgII L; P[8],G4 
sgII L; P[8],G9 sgII L) and several rare gene combinations, as well 
(P[4],G2 sgI L; P[6],G4 sgII L; P[8],G9 sgI L; P[9],G6 sgI L; P[9],G3 
sgI L; P[14],G6 sgI L; P[4],G1 S).  
 
Sequencing and phylogenetic analysis of the outer capsid genes of rare 
and emerging rotavirus strains. We characterized the VP7 and VP4 
genes of the unusual human strain, G6, as well as the VP7 and VP4 
genes of the pandemic serotype G9 human strain, and lastly the VP4 
gene of P[6] rotaviruses, a relatively rare genotype in Hungary.  
 
Molecular analysis of P[9],G6 and P[14],G6 strains. We identified 
three phylogenetic lineages of the VP7 gene of serotype G6 specificity. 
This analysis revealed close genetic relationship of these strains to 
representative strains of caprine, bovine, and buffalo origin. The single P 
untypeable G6 strain was found to be of genotype P[14], while all the 
remaining G6 strains carried P[9] VP4 specificity representing two 
distinct genetic lineages.  
 
Molecular analysis of P[8],G9 strains. Serotype G9 rotaviruses were 
detected  in Hungary for the first time in 1998 and soon after their first 
description they have emerged to become the second most frequent 
serotype.  
Our computer analysis on the VP7 gene of G9 strains identified the 
globally important lineage that has also been circulating in a variety of 
countries throughout the world (United States, India, Australia, Malawi, 
Great Britain, The Netherlands, Italy, Albania, South Africa, Thailand, 
Japan, Belgium, Slovenia, Sweden) for the past ten years. Strains within 
this lineage clearly segregate from those strains that were identified in 
the 1980s in India, Japan, and the United States. The presumed ancestor 




Molecular analysis of P[6],G4 strains. We identified two phylogenetic 
lineages among the uncommon Hungarian VP4 specificity, P[6], none of 
which was known from earlier studies. Later, in a cooperation with our 
Italian colleagues, we analyzed a number of porcine P[6] strains. This  
study revealed that at least one of our human P[6] lineage may have 
originated from swine rotaviruses. 
 
In conclusion, in agreement with others’ observations our phylogenetic 
analyses demonstrate that serotype G6, G9 and genotype P[6] strains 
have transmitted from their respective hosts to humans on several, 
independent occasions. 
 
Summary; presentation of novel findings 
 
Since the mid 1990s, the aim to alleviate the burden of rotavirus-related 
infections prompted the initiation of national surveillance program in 
numerous countries in order to understand the true significance of 
rotavirus disease and to explore the genetic and antigenic diversity of 
concurrently circulating rotavirus strains.  
Determination of the social and economic losses resulting from 
rotavirus infection provides crucial information for health care policies 
to understand the possible local benefits of a national immunization 
program (whether decrease in fatal cases and/or in costs associated with 
the treatment can be expected). In our country, a single multi-center 
survey has been conducted in this topic, and its remarkable conclusions 
were published in 1999 in the Supplement of Acta Paediatrica. Those 
results demonstrated that the incidence of hospitalization due to 
rotavirus is among the highest across Europe and the estimated direct 
costs of treatment are ~5 Million US$ each year.   
The perception that serotype-specific (homotypic) immunity is 
important in the protection against (re-)infections with rotavirus resulted 
in the idea of constructing polyvalent vaccines and a decade later, when 
the introduction of the first rotavirus vaccine, RotaShieldTM, was at 
threshold, has prompted to collect more comprehensive data on 
serotypes and genotypes of rotaviruses circulating in the community. 
The original aim of the present study was to participate in these 
international efforts.  
 
 10
These surveillance studies focus on the sero- and genotyping of the 
outer capsid antigens. However, in order to follow the epidemic spread 
of individual rotavirus strains, to detect infections with multiple strains 
(i.e., mixed infections), and to identify unusual and novel strains, it 
might be necessary to include other typing methods (e.g., subgrouping, 
electropherotyping, and nucleic acid sequencing) in the diagnostic 
arsenal. Both serotype-specific MAb-ELISA and multiplex genotyping 
RT-PCR are widely used methods in the analysis of antigen specificities. 
In our survey, we utilized both techniques for G typing but only RT-
PCR based genotying was used for P typing as reliable, type-specific 
MAbs to determine the VP4 specificity are currently not available. In 
certain instances nucleic acid sequencing and phylogenetic analysis were 
used to confirm the typing results. 
In the view of our aims, the following conclusions and 
achievements were made:  
 
- Among children admitted to hospital with infectious intestinal 
disease, the proportion of rotavirus-positive cases is higher than 
proportion of cases associated with infection with enteric bacteria 
(Salmonella, Shigella és Campylobacter). 
- By the routine use of PAGE we were able to perform basic 
molecular epidemiologic investigation on the majority of strains 
(~80%), this method was used as a screening technique to 
distinguish common and rare strains and was proven to be useful 
to select individual strains for further characterization. 
- Serotyping MAb-ELISA allowed us to determine the G type for a 
large number of strains.  
- We set up multiplex RT-PCR based genotyping assays in the 
epidemiological study of rotaviruses. (This was a great 
breakthrough not only in the enhancement of sensitivity but also in 
the increase of specificity.) A number of strains untypeable by 
serotyping MAb-ELISA was typeable by RT-PCR. 
- The combination of MAb-ELISA and RT-PCR results helped us 
observe the trends in the epidemiology of rotavirus strains. We 
observed substantial differences in both temporal and geographical 
distribution of serotypes.  
- We identified the globally important, pandemic serotype G9 
strains, which have been in circulation in Hungary since their first 
detection. Our sequence- and phylogenetic analysis demonstrated 
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that the G9 strains having circulated in Hungary between 1998 and 
2001 belong to the globally emerging predominant phylogenetic 
lineage and are easily separated from strains that were identified in 
some exotic areas as well as from strains that were identified in the 
1980s.  
- The genotyping RT-PCR assay and the molecular characterization 
revealed the circulation of five genotypes of the minor outer capsid 
antigen, VP4. However, unlike for the G type specificities, we 
were unable to fully explore the geographical and temporal 
distribution of the identified P types. 
- Compiling the RNA profile, subgroup, and sero/-genotype 
specificities we identified the epidemiologically major and minor 
strains including the presumably reassorted rare rotaviruses. In the 
study period (between 1992 and 2003), partly due to the 
introduction of molecular techniques we identified several antigen 
combinations, which were not detected earlier (e.g., P[9],G3; 
P[9],G6; P[14],G6; P[6],G4; P[4],G1). 
- The outer capsid antigens of selected unusual strains (P[14],G6; 
P[9],G6 and P[6],G4) were characterized by sequencing and 
phylogenetic analysis. Some of these strains demonstrated genetic 
relatedness with certain animal strains, mainly of porcine and 
bovine origin, suggesting that they were introduced in the human 
population via interspecies transmission. A few of these unusual 
strains have not yet been identified in humans in other parts of the 
world, although their possible animal ancestors were detected.  
- At present, it seems to be a unique phenomenon that serotype G6 
strains are endemic in the Hungarian population, even though these 
are only minor members of the circulating rotaviruses (with a 
relative prevalence of ~1%); these strains were detected for the 
first time in 1995 and since then they have been circulating as far 
as the last studied season, 2002-2003. The molecular 
characterization of these G6 strains revealed that they may have 
been introduced to humans on several, independent interspecies 
transmission events. 
- Some of the rare Hungarian rotavirus strains have been adapted to 
cell culture and these strains are now in the rotavirus strain 
collection at the NIH. 
- It is well known from the literature that as much as 5-40% of 
strains subjected to antigen typing remain untypeable. Our findings 
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correlate with these data. Therefore, one can assume that, at least a 
small proportion of these samples might be serotype G6. To try to 
help explore the epidemiological importance of these strains in 
humans, we designed and utilized type-specific oligonucleotide 
primers for RT-PCR based genotyping assays. The primers were 
proven to be useful in the detection of a variety of human G6 
strains having isolated in Hungary and other parts of the world. 
- In order to help health policy makers in their future decision about 
the possible introduction of rotavirus vaccines in Hungary we 
presented the results of our survey in several national and 
international conferences, and in a variety of Hungarian and 
international scientific journals. 
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